pubmed-article:11115820 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11115820 | lifeskim:mentions | umls-concept:C0242275 | lld:lifeskim |
pubmed-article:11115820 | lifeskim:mentions | umls-concept:C0039872 | lld:lifeskim |
pubmed-article:11115820 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
pubmed-article:11115820 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:11115820 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:11115820 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:11115820 | pubmed:dateCreated | 2001-1-30 | lld:pubmed |
pubmed-article:11115820 | pubmed:abstractText | Multiorgan failure is a severe life threatening state where present therapeutic approaches are suboptimal. Epidermal growth factor (EGF) is a potent stimulant of repair in in vitro and in vivo models. We therefore examined its potential beneficial effect in reducing mortality and injury induced by the noxious agent thioacetamide (TAA). | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:language | eng | lld:pubmed |
pubmed-article:11115820 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11115820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115820 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11115820 | pubmed:month | Jan | lld:pubmed |
pubmed-article:11115820 | pubmed:issn | 0017-5749 | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:Lopez-SauraPP | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:FloydD NDN | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:PlayfordR JRJ | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:RamirezDD | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:MarchbankTT | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:BerlangaJJ | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:CaballeroM... | lld:pubmed |
pubmed-article:11115820 | pubmed:author | pubmed-author:GozalezRR | lld:pubmed |
pubmed-article:11115820 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11115820 | pubmed:volume | 48 | lld:pubmed |
pubmed-article:11115820 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11115820 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11115820 | pubmed:pagination | 34-40 | lld:pubmed |
pubmed-article:11115820 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:meshHeading | pubmed-meshheading:11115820... | lld:pubmed |
pubmed-article:11115820 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11115820 | pubmed:articleTitle | Epidermal growth factor reduces multiorgan failure induced by thioacetamide. | lld:pubmed |
pubmed-article:11115820 | pubmed:affiliation | Centre for Genetic Engineering and Biotechnology, National Centre for Scientific Research, Havana, Cuba. | lld:pubmed |
pubmed-article:11115820 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11115820 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11115820 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11115820 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11115820 | lld:pubmed |